32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This was a Retrospective Case-Control study conducted at the Antiretroviral department, Rajiv Gandhi Institute of Medical Sciences(RIMS),Kadapa,India.The study was conducted to assess the incidence, prevalence, severity pattern, predictability, preventability of adverse drug reactions (ADRs) to HAART, and to identify the risk factors for ADRs in HIV-positive patients receiving HAART. Patients between 2010 and May 2011 newly registered HIV patients on HAART therapy of either sex were included. Demographic details, occupations details, education, CD4 cell count, weight and hemoglobin…mehr

Produktbeschreibung
This was a Retrospective Case-Control study conducted at the Antiretroviral department, Rajiv Gandhi Institute of Medical Sciences(RIMS),Kadapa,India.The study was conducted to assess the incidence, prevalence, severity pattern, predictability, preventability of adverse drug reactions (ADRs) to HAART, and to identify the risk factors for ADRs in HIV-positive patients receiving HAART. Patients between 2010 and May 2011 newly registered HIV patients on HAART therapy of either sex were included. Demographic details, occupations details, education, CD4 cell count, weight and hemoglobin (Hb),Laboratory data, drugs used and suspected ADRs observed were collected.This is the First Retrospective Case-Control study that was designed to evaluate the incidence of ARV therapy-induced ADRs in Indian HIV-positive patients.
Autorenporträt
B. Akshaya Srikanth, is a Clinical Pharmacist at Rajiv Gandhi Institute of Medical Sciences(RIMS) of Kadapa,India. He completed his Pharm.D at the P.R.R.M.College of Pharmacy with a thesis entitled "Incidence of Adverse drug reactions in HIV positive patients using Highly Active Antiretroviral Therapy" of the Kadapa region, INDIA.